RA Medical Systems (RMED) Stock

DelistedNYSE American: RMEDRa Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States.

0.38
Final close · Oct 19, 2023

RMED is no longer traded. RA Medical Systems was delisted from the NYSE American in October 2023.

Prices on this page are historical; the last trade was October 19, 2023 at $0.38.

RA Medical Systems stock price history

Split-adjusted closes, 2018–2023

RMED final trading statistics

Final close
$0.38
Final trading day
Oct 19, 2023
Market cap at delisting
$2.45M
Shares outstanding
6.46M
Final 52-week range
$0.34 – $7.25
Avg. volume (final 3 mo.)
100,499
All-time high (split-adj.)
$25000.00 · Sep 2018
All-time low (split-adj.)
$0.36 · Oct 2023
Return since IPO
-100.0%
Beta
0.18
Book value / share
$6.81
Price / book
0.06
Final 52 wk
0.347.25

RA Medical Systems earnings per share

Earnings per share

RA Medical Systems revenue & net income

RevenueNet income

RA Medical Systems annual financials

RA Medical Systems revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2022$14.0K-$26.9M-$35.14
FY2021$22.0K-$27.3M-$122.76
FY2020$4.41M-$36.0M-$1580.50
FY2019$7.20M-$57.0M-$3801.16
FY2018$6.26M-$30.8M-$1476.63

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About RA Medical Systems

Ra Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina.

RA Medical Systems stock FAQ

What happened to RA Medical Systems stock?

RA Medical Systems stock was delisted from the NYSE American. Its final close was $0.38 on October 19, 2023.

Is RMED stock still trading?

No. RMED was delisted from the NYSE American in October 2023 and no longer trades on a U.S. exchange.

What was the last price of RMED stock?

RMED closed at $0.38 on its final trading day, October 19, 2023, for a market value of about $2.45M.

What were RA Medical Systems's revenue and earnings in its last full fiscal year?

RA Medical Systems reported revenue of $14.0K and net income of -$26.9M in fiscal 2022, its last full year as a public company.

When did RA Medical Systems go public?

RA Medical Systems stock began trading on August 30, 2018.

Medical Devices stocks to research

All Healthcare stocks →